AnaptysBio, Inc. ANAB Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 17.6%-2.9pp | 20.4%+37.3pp | -16.9%+53.0pp | -69.9%+19.7pp | -89.6%+36.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.6×+0.2× | 0.4×+0.1× | 0.3×+0.1× | 0.3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 7.6×-1.5× | 9.1×+0.4× | 8.7×+0.5× | 8.2×0.0× | 8.2×-1.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×— | —— | —— | 0.5×+0.2× | |
| Net debt / EBITDA | -6×-1.1× | -4.9×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $0.44-65.7% | $1.29+228% | -$1.01+34.7% | -$1.55-240% | $1.11-55.5% | |
| Valuation | ||||||
| Market capitalization | $1.59B+18.8% | $1.34B+56.7% | $856.53M+25.0% | $685.15M+20.2% | $570.1M+41.5% | |
| Price / sales | 6.9×+1.1× | 5.7×+0.7× | 5.1×-0.5× | 5.6×+0.5× | 5.1×+0.7× | |
| Price / book | 125.1×+89.0× | 36.1×— | —— | —— | 16.8×+11.1× | |
| EV / EBITDA | 32.6×+9.8× | 22.8×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do AnaptysBio, Inc.'s ratios come from?
- Every ratio is computed from AnaptysBio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
